A new genetic target for potential therapy of sickle cell disease (SCD) was discovered by a research team from Dana-Farber/Boston Children's Cancer and Blood Disorders Center and other institutions. The target, called an enhancer, controls a molecular switch in red blood cells called BCL11A that, in turn, regulates hemoglobin production. The researchers-led by Daniel Bauer, MD, PhD, and Stuart Orkin, MD, of Dana-Farber/Boston Children's-reported their findings ...You have just read an article categorized health
titled Sickle Cell Disease Can Be Precisely Targeted By Newly Discovered Gene Regulator.
Written by:
editor - Wednesday, October 16, 2013
There are currently no comments for "Sickle Cell Disease Can Be Precisely Targeted By Newly Discovered Gene Regulator"
Post a Comment